These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 32659267)

  • 21. SARS-CoV-2 and the cardiovascular system.
    Hafiane A
    Clin Chim Acta; 2020 Nov; 510():311-316. PubMed ID: 32681935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
    Nowill AE; de Campos-Lima PO
    J Immunol; 2020 Nov; 205(10):2566-2575. PubMed ID: 32958687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ACE2 receptor expression in testes: implications in coronavirus disease 2019 pathogenesis†.
    Verma S; Saksena S; Sadri-Ardekani H
    Biol Reprod; 2020 Aug; 103(3):449-451. PubMed ID: 32427288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocrine and metabolic link to coronavirus infection.
    Bornstein SR; Dalan R; Hopkins D; Mingrone G; Boehm BO
    Nat Rev Endocrinol; 2020 Jun; 16(6):297-298. PubMed ID: 32242089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI).
    Sokolowska M; Lukasik ZM; Agache I; Akdis CA; Akdis D; Akdis M; Barcik W; Brough HA; Eiwegger T; Eljaszewicz A; Eyerich S; Feleszko W; Gomez-Casado C; Hoffmann-Sommergruber K; Janda J; Jiménez-Saiz R; Jutel M; Knol EF; Kortekaas Krohn I; Kothari A; Makowska J; Moniuszko M; Morita H; O'Mahony L; Nadeau K; Ozdemir C; Pali-Schöll I; Palomares O; Papaleo F; Prunicki M; Schmidt-Weber CB; Sediva A; Schwarze J; Shamji MH; Tramper-Stranders GA; van de Veen W; Untersmayr E
    Allergy; 2020 Oct; 75(10):2445-2476. PubMed ID: 32584441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer?
    Hays P
    Future Oncol; 2020 Jul; 16(20):1463-1474. PubMed ID: 32456461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.
    Tai W; He L; Zhang X; Pu J; Voronin D; Jiang S; Zhou Y; Du L
    Cell Mol Immunol; 2020 Jun; 17(6):613-620. PubMed ID: 32203189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).
    Chang FY; Chen HC; Chen PJ; Ho MS; Hsieh SL; Lin JC; Liu FT; Sytwu HK
    J Biomed Sci; 2020 Jun; 27(1):72. PubMed ID: 32498686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV).
    Noor R
    Arch Microbiol; 2021 Jul; 203(5):1943-1951. PubMed ID: 33682075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors.
    Stilhano RS; Costa AJ; Nishino MS; Shams S; Bartolomeo CS; Breithaupt-Faloppa AC; Silva EA; Ramirez AL; Prado CM; Ureshino RP
    FASEB J; 2020 Nov; 34(11):14103-14119. PubMed ID: 32965736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.
    Bojkova D; Klann K; Koch B; Widera M; Krause D; Ciesek S; Cinatl J; Münch C
    Nature; 2020 Jul; 583(7816):469-472. PubMed ID: 32408336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic.
    Brufsky A
    J Med Virol; 2020 Jul; 92(7):770-775. PubMed ID: 32293710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 and COVID-19: How much do we know?
    Wang M; Liao Z
    Acta Virol; 2020; 64(3):288-296. PubMed ID: 32985201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 and Crosstalk With the Hallmarks of Aging.
    Salimi S; Hamlyn JM
    J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(9):e34-e41. PubMed ID: 32544216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation.
    Yang D; Chu H; Hou Y; Chai Y; Shuai H; Lee AC; Zhang X; Wang Y; Hu B; Huang X; Yuen TT; Cai JP; Zhou J; Yuan S; Zhang AJ; Chan JF; Yuen KY
    J Infect Dis; 2020 Aug; 222(5):734-745. PubMed ID: 32563187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 and the immune system.
    Paces J; Strizova Z; Smrz D; Cerny J
    Physiol Res; 2020 Jul; 69(3):379-388. PubMed ID: 32469225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion.
    Low ZY; Zabidi NZ; Yip AJW; Puniyamurti A; Chow VTK; Lal SK
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects.
    Michalakis K; Ilias I
    Diabetes Metab Syndr; 2020; 14(4):469-471. PubMed ID: 32387864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative overview of COVID-19, MERS and SARS: Review article.
    Liu J; Xie W; Wang Y; Xiong Y; Chen S; Han J; Wu Q
    Int J Surg; 2020 Sep; 81():1-8. PubMed ID: 32730205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adaptive immunity against SARS-CoV-2].
    Combadière B
    Med Sci (Paris); 2020 Oct; 36(10):908-913. PubMed ID: 32960167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.